Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Canopy Growth

Tilray Brands

As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with projected growth reaching $41 billion by 2025. This massive market is appealing to Canadian companies seeking new revenue streams. Florida, in particular, is considering the legalization of recreational cannabis, which could unlock significant growth for Canadian cannabis companies with existing U.S. ties. If Florida joins the ranks of legal states, Canadian companies like Tilray, Canopy Growth, and Cronos Group could capitalize on this opportunity. These stocks are increasingly appealing to investors looking to benefit from potential changes in the U.S. market.

Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up

Amneal Pharmaceuticals

Amphenol

Business First Bancshares Inc.

Carriage Services

Invest in stocks of AMRX, CRON, CSV, BFST and APH to tap their high-efficiency levels.

5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility

TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024

TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is proud to announce that its award-winning brand Spinach® has risen to the best-selling cannabis brand in the Canadian market.1 Spinach's market share outperformance represents Cronos' relentless commitment to quality, innovation, and bringing differentiated products to the competitive Canadian adult-use market.

Spinach® Is the Number One Cannabis Brand in Canada

For most of the campaign cycle, those bullish on cannabis stocks viewed a Vice President Kamala Harris presidency as the most beneficial to the sector.

3 Cannabis Stocks to Monitor as the Election Approaches

With most marijuana stocks still showing volatile trading is now the time to buy? Well, it's not such an easy answer as some may find the volatile behavior of marijuana stocks to be in their favor. The cannabis sector has been showing a large amount of volatility for some time. What this means is the slightest factor can impact how the better part of the sector trades. Often leading to a downtrend for most marijuana stocks until such time there is a means to see a recovery.

These Canadian Marijuana Stocks Could Be The Winners You Need

SNDL Inc.

Over the last several days some marijuana stocks have begun to pick up in momentum. There have been several attempts to show good faith in the legalization efforts for cannabis markets across the USA. Recently Trump has shown his support for legal cannabis in Florida under the right conditions. From this news, more people began to speculate that Trump's support can mean big things for legal cannabis. In addition to fueling more profitable trading in the hopes of better reform measures.

3 Marijuana Stocks To Watch On September 11th

Aurora Cannabis

OrganiGram Holdings Inc.

Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.

3 Marijuana Stocks To Watch In The Stock Market Today

The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.

Top Canadian Marijuana Stocks To Watch In 2024

The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.

3 Weed Stocks Sinking on Reclassification Hearing Update

The DEA scheduled a public meeting about cannabis rescheduling for Dec. 2, 2024. It's possible that cannabis won't be rescheduled before the next president takes office, if at all.

Why Cronos Group Stock Is Sinking Today

Initiating coverage on Cronos stock with a "Strong Buy" rating. Cannabis industry tailwinds, conservative growth approach, and geographic expansion support Cronos' growth acceleration and EBITDA margin improvement. A strong cash buffer of $848 million coupled with a zero-debt balance sheet provides flexibility for organic and acquisition-driven growth.

Buy Cronos Stock Before It Surges Higher

What's next for marijuana stock investors as the sector's recent rise in trading has people talking. Recently there has been an increase in trading that allowed some investors to take profits. Yet in true cannabis fashion, this rise in trading was short-lived. Yet it is moments like this where newfound confidence can be found when looking to invest in legal cannabis. The growth and boom of legal cannabis are still going strong and developing day by day.

3 Of Today's Top Canadian Marijuana Stock Picks For Investors

IAMGOLD

Li Auto Inc.

Marathon Digital Holdings

MINISO Group Holding

PACS Group, Inc.

Tempus AI Inc

The S&P 500 index touched highs of 5,670 in July. Over the last one month, the index movement has been volatile with a downward bias.

7 Growth Stocks to Buy on Corrections for 3X Returns by 2026

Curaleaf Holdings, Inc.

In the last five years, cannabis stocks have gone through brief phases of optimism that has been followed by an extended period of depression. The reason is no secret as the industry suffers on the back of regulatory headwinds, intense competition, overcapacity, and cash burn.

3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030

The Canadian cannabis purveyor saw a leap in revenue for its second quarter. This was largely, but not entirely, due to higher sales in its home market.

Why Investors Were High on Cronos Group Today

Cronos Group Inc. (NASDAQ:CRON ) Q2 2024 Results Conference Call August 8, 2024 8:30 AM ET Company Participants Shayne Laidlaw - IR Mike Gorenstein - Chairman, President and CEO James Holm - CFO Conference Call Participants Yewon Kang - Canaccord Genuity Operator Good morning. My name is Andrea, and I will be your conference operator today.

Cronos Group Inc. (CRON) Q2 2024 Earnings Call Transcript

Net revenue in Q2 2024 increased by 46% year-over-year to $27.8 million Industry-leading balance sheet with $848 million in cash and cash equivalents Announced expansion of Cronos GrowCo designed to fuel global growth TORONTO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2024 second quarter business results. “Cronos achieved its highest quarterly net revenue on record in Q2 2024 at $27.8 million, up 46% year-over-year.

Cronos Group Reports 2024 Second Quarter Results

DraftKings

EHang Holdings Ltd - ADR

First Solar

Ibotta Inc

The recent market correction is a reminder to investors that it's important to remain grounded even during bull markets. By this, I imply having a balanced portfolio and staying away from overvalued stocks.

7 Growth Stocks That Could 7X in the Next 7 Years

The potential for marijuana legalization in the U.S. generated a lot of excitement in the cannabis industry. The rescheduling of the drug from a Schedule I controlled dangerous substance to a Schedule III drug was a big step forward.

3 Cannabis Stocks to Sell in August Before They Crash & Burn

Cannabis stocks have been through an extended period of depression. Overcapacity, regulatory headwinds, competition, and cash burn have contributed to the decline in the cannabis industry.

What Are the Hottest Cannabis Stocks Right Now? 3 Top Picks.

Cronos Group's Chief Executive Mike Gorenstein was giving a tour of one of the company's cannabis growing facilities in 2018 when he heard that his company's stock was down sharply.

How the head of cannabis company Cronos dealt with a negative report from indicted short seller Andrew Left

Marijuana stock investors are prepping for future trading. Many who are invested in cannabis are focused on the long term. With how volatile the sector can be there have been some moments to take profits. However, with the need for better regulations and all-around reform planning for the future is where many feel the money is. Currently, there is no federal reform in place even with the DEA's approval to reschedule cannabis.

News for Cronos Group Stock (CRON)